These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2882044)

  • 1. Enzyme pathology of human mesotheliomas.
    Greengard O; Head JF; Chahinian AP; Goldberg SL
    J Natl Cancer Inst; 1987 Apr; 78(4):617-22. PubMed ID: 2882044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymic composition and growth rate of human pleural mesothelioma transplants in nude mice.
    Head JF; Chahinian AP; Greengard O
    Cancer Biochem Biophys; 1991 Aug; 12(2):127-36. PubMed ID: 1769009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical measure of the volume doubling time of human pulmonary neoplasms.
    Greengard O; Head JF; Goldberg SL; Kirschner PA
    Cancer; 1985 Apr; 55(7):1530-5. PubMed ID: 2983858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary carcinoid tumors: enzymic discriminants, growth rate, and early age of inception.
    Greengard O; Head JF; Goldberg SL; Kirschner PA
    Cancer Res; 1986 May; 46(5):2600-5. PubMed ID: 2870799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma.
    Soini Y; Kahlos K; Puhakka A; Lakari E; Säily M; Pääkkö P; Kinnula V
    Br J Cancer; 2000 Oct; 83(7):880-6. PubMed ID: 10970689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of patterns of metastasis between malignant pleural mesotheliomas and pulmonary carcinomas].
    Scharmach M; Neumann V; Müller KM; Fischer M
    Pneumologie; 2006 May; 60(5):277-83. PubMed ID: 16703480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
    Sheibani K; Battifora H; Burke JS
    Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
    López-Ríos F; Chuai S; Flores R; Shimizu S; Ohno T; Wakahara K; Illei PB; Hussain S; Krug L; Zakowski MF; Rusch V; Olshen AB; Ladanyi M
    Cancer Res; 2006 Mar; 66(6):2970-9. PubMed ID: 16540645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
    Gotzos V; Vogt P; Celio MR
    Pathol Res Pract; 1996 Feb; 192(2):137-47. PubMed ID: 8692714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
    Ordóñez NG
    Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
    Esquius Soriguera J; Alejo Sánchez M; Padilla Navas I; Rodríguez Casquero C; León González C
    Rev Clin Esp; 1989 Oct; 185(6):303-5. PubMed ID: 2623239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathologic study of pleural and peritoneal mesotheliomas of rats induced by asbestos].
    Tan XM
    Zhonghua Bing Li Xue Za Zhi; 1991 Sep; 20(3):187-9. PubMed ID: 1782687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
    Warhol MJ; Hickey WF; Corson JM
    Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.
    Soini Y; Kinnula V; Kahlos K; Pääkkö P
    J Clin Pathol; 2006 Mar; 59(3):250-4. PubMed ID: 16505274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of diffuse pleural mesotheliomas].
    Loddenkemper R
    Pneumologie; 1991 Apr; 45(4):159-61. PubMed ID: 1876593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients.
    Kerrigan SA; Turnnir RT; Clement PB; Young RH; Churg A
    Cancer; 2002 Jan; 94(2):378-85. PubMed ID: 11905410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects].
    Chenard-Neu MP; Bellocq JP; Maier A; Batzenschlager A
    Ann Pathol; 1990; 10(1):20-7. PubMed ID: 2328062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.